TABLE 1.

Clinical Characteristics, Treatments, and Temporal Relationship Between Pulmonary Adenocarcinoma, Chemotherapy, and Radiotherapy of Patients

Patient No.	Primary Oncologic Diagnosis	Age at Primary Diagnosis	Sex	Age at Thoracotomy	Pulmonary Adenocarcinoma Preceeded or Followed Cancer Therapy?	Prior Chemotherapeutic Agents	Pulmonary Irradiation
1	Wilms’ tumor	7	M	13	Unknown	Actinomycin-D	1200 cGy
						Vincristine
						Doxorubicin
						Carboplatin
						Etoposide
						Cyclophosphamide
2	Neuroblastoma	3	F	10a	Followed	Vincristine	None
						Cyclophosphamide
						Cisplatin
						Carboplatin
						Doxorubicin
						Etoposide
						Ifosphamide
						Topotecan
3	Osteosarcoma	19	M	20	Unknown	Cisplatin	None
						Doxorubicin
						High-dose methotrexate
4	Osteosarcoma	18	M	19	Preceded	Cisplatin	None
						Doxorubicin
						High-dose methotrexate
						Pamidronate
5	Osteosarcoma	23	F	24	Preceded	Cisplatin	None
						Doxorubicin
						High-dose methotrexate
6	Osteosarcoma	11	F	12	Preceded	Cisplatin	None
						Doxorubicin
						High-dose methotrexate
						L-MTP-PE
7	Chondrosarcoma	14	F	15	Unknown	Vincristine	None
						Doxorubicin
						Cyclophosphamide
						Ifosfamide
						Etoposide
8	Osteosarcoma	14	M	14	Preceded	COG AOST0121	None

^aUnderwent thoracoscopic biopsy at outside institution.

L-MTP-PE, liposomal muramyltripeptide phosphatidylethanolamine; COG, Children’s Oncology Group.